Analytical Data
-
基因名
cap5A
- Application
-
种属
Staphylococcus aureus
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P95695
-
表达区间
1-222aa
-
分子量
26.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cap5A, an important protein found in certain bacterial species, has garnered significant interest in the field of microbiology and biotechnology due to its crucial role in virulence and adaptation. This protein is primarily associated with the pathogenicity of bacterial strains, influencing their ability to adhere to host tissues and evade the immune response. Research into Cap5A has revealed its involvement in forming capsular structures, which serve as protective barriers against host defense mechanisms, thereby enhancing the survival and infectious capacity of bacteria. Understanding the molecular mechanisms underlying Cap5A's function provides valuable insights into bacterial pathogenesis and opens up potential avenues for developing novel therapeutic strategies, including vaccines and antibody treatments. Furthermore, the recombinant production of Cap5A offers opportunities for studying its structure and function in detail, facilitating the exploration of its applications in biomedicine and vaccine development. As antibiotic resistance becomes a growing concern, targeting virulence factors like Cap5A might represent a promising approach to combat bacterial infections. Thus, ongoing research into the recombinant expression and functional characterization of Cap5A is crucial for advancing our understanding of bacterial behavior and developing effective interventions.












